Pd-1/Pd-L1 inhibitor 3

CAS: 1629654-95-0

Ref. 3D-EQC65495

Produktinformation

• Name: Pd-1/Pd-L1 inhibitor 3
• Marke: Biosynth

Beschreibung

PD-1/PD-L1 inhibitor 3 is an activating molecule that binds to PD-L1, inhibiting its interaction with the inhibitory receptor PD-1. This drug is a small molecule that blocks the binding of PD-L1 and PD-1, which prevents the inhibition of T cell proliferation and function. In this way, PD-L1 inhibitor 3 activates T cells and enhances anti-tumor activity by preventing tumor escape from immune surveillance. Approved in 2017, this drug has been shown to be safe in patients with non-small cell lung cancer (NSCLC) and other types of cancer. The most common side effects are fatigue, diarrhea, nausea, vomiting, rash, constipation, headache, fever, cough and decreased appetite.

Chemische Eigenschaften

• Molekulargewicht: 1,852.2 g/mol
• Formel: C₈₉H₁₂₆N₂₄O₁₈S
• Reinheit: Min. 95%